222 related articles for article (PubMed ID: 33260050)
21. Inhibition of Estrogen Signaling Reduces the Incidence of
Baek HJ; Kim SE; Choi EK; Kim JK; Shin DH; Park EJ; Kim TH; Kim JY; Kim KG; Deng CX; Kim SS
Int J Biol Sci; 2018; 14(12):1755-1768. PubMed ID: 30416390
[TBL] [Abstract][Full Text] [Related]
22. NF-κB at the Crossroads of Normal Mammary Gland Biology and the Pathogenesis and Prevention of
Sau A; Cabrita MA; Pratt MAC
Cancer Prev Res (Phila); 2018 Feb; 11(2):69-80. PubMed ID: 29101208
[TBL] [Abstract][Full Text] [Related]
23. Estrogen and BRCA1 deficiency synergistically induce breast cancer mutation-related DNA damage.
Chen J; Liu J; Zeng P; Zhao C; Liu X; Sun J; Wang J; Fang P; Chen W; Ding J
Biochem Biophys Res Commun; 2022 Jul; 613():140-145. PubMed ID: 35561581
[TBL] [Abstract][Full Text] [Related]
24. MYB regulates the DNA damage response and components of the homology-directed repair pathway in human estrogen receptor-positive breast cancer cells.
Yang RM; Nanayakkara D; Kalimutho M; Mitra P; Khanna KK; Dray E; Gonda TJ
Oncogene; 2019 Jun; 38(26):5239-5249. PubMed ID: 30971760
[TBL] [Abstract][Full Text] [Related]
25. The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer.
Tommiska J; Bartkova J; Heinonen M; Hautala L; Kilpivaara O; Eerola H; Aittomäki K; Hofstetter B; Lukas J; von Smitten K; Blomqvist C; Ristimäki A; Heikkilä P; Bartek J; Nevanlinna H
Oncogene; 2008 Apr; 27(17):2501-6. PubMed ID: 17982490
[TBL] [Abstract][Full Text] [Related]
26. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
27. The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.
Gorski JJ; Kennedy RD; Hosey AM; Harkin DP
Clin Cancer Res; 2009 Mar; 15(5):1514-8. PubMed ID: 19223511
[TBL] [Abstract][Full Text] [Related]
28. BRCA1 mutation influences progesterone response in human benign mammary organoids.
Davaadelger B; Choi MR; Singhal H; Clare SE; Khan SA; Kim JJ
Breast Cancer Res; 2019 Nov; 21(1):124. PubMed ID: 31771627
[TBL] [Abstract][Full Text] [Related]
29. The role of BRCA1 in DNA damage response.
Wu J; Lu LY; Yu X
Protein Cell; 2010 Feb; 1(2):117-23. PubMed ID: 21203981
[TBL] [Abstract][Full Text] [Related]
30. Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations.
Communal L; Vilasco M; Hugon-Rodin J; Courtin A; Mourra N; Lahlou N; Le Guillou M; Perrault de Jotemps M; Chauvet MP; Chaouat M; Pujol P; Feunteun J; Delaloge S; Forgez P; Gompel A
Oncotarget; 2016 Jul; 7(29):45317-45330. PubMed ID: 27246982
[TBL] [Abstract][Full Text] [Related]
31. Pathologic features and immunophenotype of estrogen receptor-positive breast cancers in BRCA1 mutation carriers.
Kaplan JS; Schnitt SJ; Collins LC; Wang Y; Garber JE; Montgomery K; West RB; Krag K; Fetten K; Lincoln A; Tung NM
Am J Surg Pathol; 2012 Oct; 36(10):1483-8. PubMed ID: 22613997
[TBL] [Abstract][Full Text] [Related]
32. A DNA repair BRCA1 estrogen receptor and targeted therapy in breast cancer.
Ratanaphan A
Int J Mol Sci; 2012 Nov; 13(11):14898-916. PubMed ID: 23203101
[TBL] [Abstract][Full Text] [Related]
33. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers.
Archey WB; McEachern KA; Robson M; Offit K; Vaziri SA; Casey G; Borg A; Arrick BA
Oncogene; 2002 Oct; 21(46):7034-41. PubMed ID: 12370825
[TBL] [Abstract][Full Text] [Related]
34. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
[TBL] [Abstract][Full Text] [Related]
35. BRCA1 inhibition of estrogen receptor signaling in transfected cells.
Fan S; Wang J; Yuan R; Ma Y; Meng Q; Erdos MR; Pestell RG; Yuan F; Auborn KJ; Goldberg ID; Rosen EM
Science; 1999 May; 284(5418):1354-6. PubMed ID: 10334989
[TBL] [Abstract][Full Text] [Related]
36. Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
Wang C; Bai F; Zhang LH; Scott A; Li E; Pei XH
Breast Cancer Res; 2018 Jul; 20(1):74. PubMed ID: 29996906
[TBL] [Abstract][Full Text] [Related]
37. p300 Modulates the BRCA1 inhibition of estrogen receptor activity.
Fan S; Ma YX; Wang C; Yuan RQ; Meng Q; Wang JA; Erdos M; Goldberg ID; Webb P; Kushner PJ; Pestell RG; Rosen EM
Cancer Res; 2002 Jan; 62(1):141-51. PubMed ID: 11782371
[TBL] [Abstract][Full Text] [Related]
38. New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines.
Crowe DL; Lee MK
Breast Cancer Res; 2006; 8(1):R1. PubMed ID: 16417649
[TBL] [Abstract][Full Text] [Related]
39. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity.
Fan S; Ma YX; Wang C; Yuan RQ; Meng Q; Wang JA; Erdos M; Goldberg ID; Webb P; Kushner PJ; Pestell RG; Rosen EM
Oncogene; 2001 Jan; 20(1):77-87. PubMed ID: 11244506
[TBL] [Abstract][Full Text] [Related]
40. BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling.
van de Ven M; Liu X; van der Burg E; Klarenbeek S; Alexi X; Zwart W; Dijcks F; Bouwman P; Jonkers J
J Pathol; 2018 Sep; 246(1):41-53. PubMed ID: 29877575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
